AIMS Medical Analysis

Classify patients with oropharyngeal dysphagia quickly; Streamline patient assessment processes in hospitals; Enhance treatment planning for dysphagia; Improve patient outcomes through rapid diagnosis; Facilitate multidisciplinary collaboration in healthcare settings.

Notable recognition as a top spin-off to watch in 2025; Participation in significant healthcare AI symposiums; Engaged in innovation challenges and pitch battles.

Main Information

• Information: AIMS MEDICAL, a spin-off of the Consorci Sanitari del Maresme in Parc TecnoCampus, develops clinical decision support software for age-related diseases. Their main product, AIMS-RISK, is a platform for the systematic and automatic screening of oropharyngeal dysphagia (OD), malnutrition (MN), and aspiration pneumonia (AP). It automates screening for thousands of patients, detecting 80-100% at risk.
• Interests: Artificial Intelligence, Health/Fitness/Wellbeing, Software Services.
• Location: Hall 8.1 - 4YFN Stand 8.1C22.1B.
• Tagged as startup: Yes.

Contact & Links

• LinkedIn: Connect on LinkedIn
• Twitter: No relevant data.
• Phone Number: +34 617758178.
• Email: Email.

Key Information

• Growth Stage: Pre-Seed.
• Country: Spain.
• Founding Year: 2022.

Company Context

• Company Name: Artificial Intelligence Massive Screening - Medical.
• Company Website: https://aimsmedical.ai/